Bill > S00520

This bill ensures that individuals with a history of ovarian cancer have the right to comprehensive genetic and genomic testing without restrictions. Specifically, the bill mandates that ovarian cancer survivors cannot be denied genetic testing or genomic tumor profiling, which includes screenings for inherited germline mutations and acquired somatic mutations. The required testing must cover genetic mutations in BRCA1 and BRCA2 genes (which are known to increase cancer risk), mutations associated with Lynch syndrome, a comprehensive rearrangement analysis of coding exons related to ovarian cancer, and any additional mutations deemed medically necessary by the patient's healthcare professional. By removing frequency caps and other potential limitations on testing, the bill aims to provide ovarian cancer survivors with more thorough and personalized medical screening options that could help detect potential future health risks or guide treatment strategies.

Budget and Finance, Health and Social Services

https://www.nysenate.gov/legislation/bills/2025/S520